Cardiologists expected this new drug to prevent heart attacks—so why did it fail?

1 month ago 9
A cause that bosom doctors wide expected to go the adjacent large limb against bosom attacks has failed successful a ample objective trial, drugmaker Novartis announced.
Read Entire Article